Home › COPD › Minnesota › Rochester
COPD clinical trials in Rochester, MN
3 studies for COPD are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Mayo Clinic in Rochester - Minnesota- Site Number : 8400005, Rochester
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 108, Rochester
Pulmonary Rehabilitation for Rural Patients With COPD
Recruiting
- Mayo Clinic in Rochester, Rochester
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Birmingham, AL18 studies
- Miami, FL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Pittsburgh, PA13 studies
- Baltimore, MD13 studies
- Dallas, TX12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer23 studies
- Multiple Myeloma23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Lung Cancer20 studies
- Chronic Lymphocytic Leukemia19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.